The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritis

Cited by (321)

Items 301–321 of 321

1. MAS in der pädiatrischen Rheumatologie
   Dirk Holzinger · 2021 · Springer Reference Medizin
2. Makrophagenaktivierung im Spannungsfeld zwischen Morbus Still, hämophagozytischer Lymphohistiozytose und Infektionserkrankungen
   Moritz Klaas, Volker Stephan, Danuta Ochab, Uwe Kölsch, Hermann Joseph Girschick · 2021 · Arthritis und Rheuma
3. Macrophage Activation Syndrome
   Sergio Davì, Francesca Minoia, Randy Quentin Cron, Angelo Ravelli · 2016 · Springer eBooks
4. Kapitel E1 Literaturverzeichnis zu Peter, Pichler, Müller-Ladner (Hrsg.): Klinische Immunologie
   2012 · Elsevier eBooks
5. Etymologia: Typhus
   Greek typhein · 2009 · Emerging infectious diseases
6. Potential markers for macrophage activation syndrome in systemic JIA
   2007 · Nature Clinical Practice Rheumatology
7. Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
   Hayley A. Gans, David B. Lewis · 2012 · Elsevier eBooks
8. MAS in der pädiatrischen Rheumatologie
   Dirk Holzinger · 2022 · Springer Reference Medizin
9. Avaliação do sCD163 como biomarcador prognóstico para gravidade em pacientes hiperinflamatórios de COVID-19
   Marlon Fortes Rocha · 2023
10. Update in Pediatric Rheumatology
    Roberta Audrey Berard, Ronald M. Laxer · 2023 · Springer eBooks
11. All available clinical data on anakinra in COVID-19: an updated comprehensive review
    Marzieh Shahrabi, Elnaz Khani, Fariba Pourkarim, Hoda Afsharirad, Mohammad Solduzian · 2024
12. Monocyte/macrophages may exert prominent roles in macrophage activation syndrome
    D. Yin, Jing-Shi Wang, Zhao Wang · 2025 · Annals of Hematology
13. Additional file 1 of Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
    Wan, Liyan, Gao, Yuting, Gu, Jieyu, Chi, Huihui, Wang, Zhihong, Qin Hu, Jia, Jinchao, Liu, Tingting, Biao Li, Jialin Teng et al. · 2021 · Figshare
14. Additional file 1 of Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study
    Heshuang Qu, Erik Sundberg, Cecilia Aulin, Manoj Kumar Neog, Karin Palmblad, Horne, Anna Carin, Granath, Fredrik, Alexandra Ek, Melén, Erik, Mia Olsson et al. · 2021 · Figshare
15. Hyperferritinemic Syndromes and Long COVID
    Marilena Stoian · 2026 · IntechOpen eBooks
16. Étude du rôle de l’inflammasome et de la kinase Styk1 dans la régulation des lymphocytes cytotoxiques
    Sébastien Fauteux‐Daniel · 2018 · theses.fr (ABES)
17. Macrophage Activation Syndrome
    Alexei A. Grom, Grant S. Schulert · 2026 · Elsevier eBooks
18. Identification of a metabolic–immune crosstalk in Still’s disease: monocyte/macrophage-derived immunometabolite itaconate dictates hepatic immunopathology via the CXCL10–CD8 T cell axis
    Junna Ye, Fang Wang, Zhuochao Zhou, Jinchao Jia, Ziang Wu, Yijun You, Nadiem Atiq, Yutong Su, Huihui Chi, Jianfen Meng et al. · 2026 · Experimental & Molecular Medicine
19. Macrophage Plasticity: Phenotypic and Functional Profiles Across Pathological Microenvironments
    Alessandra Falda · 2026 · International Journal of Molecular Sciences
20. Soluble CD25 as a potential prognostic biomarker for pediatric septic shock and its comparison with hemophagocytic lymphohistiocytosis
    T.B. GARCIA, V. Knight, H. F. Scott · 2026 · BMC Research Notes
21. Construction and evaluation of a chronic arthritis animal model induced by persistent activation of toll‐like receptors via lipopolysaccharide stimulation
    Fengming Li, Qiang Luo, Xinglin Wu, Yuxiao Chen, Xuemei Tang · 2026 · Animal Models and Experimental Medicine